NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

In retrospect, it is hard to avoid the conclusion that Fauci, who proclaimed, "I represent science," purposefully lied and ...

NIH now has a list – reviewed by NPR – of 130 of these awards from one part of the NIH, the National Institute of Allergy and ...

Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...

As a result of the stop work order, Vaxart said it had been forced to lay off 10% of its workforce. The company entered the ...

How Infectious Disease Doctors Can Keep Up in a Rapidly Evolving Field As with most areas of medicine, advances in infectious diseases are accelerating at a rapid clip, and it’s understandable that as ...

Researchers evaluated the potential clinical impact and cost-effectiveness of administering long-acting, injectable ...

NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.

Appili Therapeutics (APLIF) announced that, the Company along with its partners, have submitted applications for four new federal funding ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers ...

Harms of race-specific lung function calculations extend to asthma and treatment, particularly in Black children.